Sunday, December 7, 2025
Today's Print

Tag: Sanofi

CA junks plea to reverse ruling on Dengvaxia

THE Court of Appeals has reaffirmed its previous decision favoring the ruling of the Quezon City Regional Trial Court that consolidated the Dengvaxia civil...

CA denies Sanofi appeal to reverse cancellation of Dengvaxia registration

The Court of Appeals denied the petition of pharmaceutical company Sanofi Pasteur, Inc. (SPI), assailing the government’s decision to revoke its certificates of product...

Healthcare company collects and repurposes used insulin pens

Global innovative healthcare company Sanofi and the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM) signed a partnership agreement, during the World Diabetes Day...

Sanofi partners with leading drugstores for prescription medicine delivery

The pandemic has made it difficult for people to move around to acquire basic necessities such as food and medicines, not just because of...

Sanofi vax test shows potentials

French pharmaceuticals giant Sanofi and Britain's GSK reported on Monday "strong immune responses" in early tests of their COVID-19 vaccine, raising hopes it could...

3 Sanofi execs arrest out over Dengvaxia row

The Quezon City Regional Trial Court has ordered the arrest of three France-based executives of Sanofi Pasteur Inc. for two counts of reckless imprudence...

Sanofi picks up Principia Biopharma for $3.7 billion

French pharmaceutical group Sanofi said Monday it has finalised acquisition of US biotech firm Principia Biopharma for $3.7 billion. The operation, first announced in August,...

Sanofi and GSK to provide 72 million vaccine doses to Canada

French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their Covid-19 vaccine candidate to the Canadian government, which...

Sanofi halts trials of COVID-19 drug

Paris—French pharmaceutical giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and...

World Roundup: – Melbourne sets six-week curfew – Vaccine race

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 11.0px; font: 10.0px 'Times New Roman'} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; text-indent: 11.9px;...

Sanofi expands US vaccine venture in COVID-19 race

French pharmaceutical giant Sanofi said Tuesday that it would invest $425 million to expand its vaccine development venture with US start-up Translate Bio as...

Closely watched arthritis drug disappoints in COVID-19 trial

Washington - An arthritis drug that was being closely watched for its potential use against COVID-19 has delivered disappointing results in clinical trials, its...

Coronavirus boosts sales for French pharma giant Sanofi

Paris - French pharmaceutical giant Sanofi said Friday that its first quarter sales surged in part due to stockpiling of the painkiller Doliprane, as...

Pharma giants Sanofi, GSK working on COVID vaccine for 2021

Pharma giants Sanofi and GlaxoSmithKline will join forces to work on a coronavirus vaccine they hope will enter clinical trials this year, potentially making...
- Advertisement -spot_img
- Advertisement -spot_img